Amphetamine Sulfate 13107-0259
Product NDC
13107-0259- Manufacturer
- Aurolife Pharma, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- January 31, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA211639
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amphetamine Sulfate | 5 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(1)
100 TABLET in 1 BOTTLE (13107-259-01)